ONVO News and Press, Organovo Holdings Inc. From 12/16/19

Combined company to operate as Tarveda Therapeutics upon closing of merger Transaction to advance Tarveda’s proprietary Pentarin® miniature drug conjugates including its two clinical programs for the treatment of solid tumor malignancies Companies to host conference ca...

3D printing has always been a niche market , with a few companies dominating the industry. That said, the space is rapidly growing and is expected to be worth over US$42.9 billion by 2025. Contributing factors to this growth will include mass customization, production of complex parts, go...

SAN DIEGO, Oct. 02, 2019 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ: ONVO) (“Organovo”) today confirmed that it has received a proposal from Viscient Biosciences (“Viscient”), an early-stage private company headquartered in San Diego, California, to acqu...

Organovo ( ONVO +5.6% ) is higher after receiving a formal merger proposal from Viscient Biosciences, whose CEO, Keith Murphy, was a co-founder of Organovo and the company's CEO and Chairman during 2007-17. More news on: Organovo Holdings, Inc., Healthcare stocks news, Stocks on the mo...

Organovo (NASDAQ: ONVO ) Q2 revenue : $668K (-3%). More news on: Organovo Holdings, Inc., Healthcare stocks news, Earnings news and commentary, Stocks on the move, , Read more ...

Organovo Holdings (NASDAQ: ONVO ): Q2 GAAP EPS of -$0.05 beats by $0.01 . Revenue of $0.7M (flat Y/Y) misses by $0.07M . Shares +2.9% . Press Release More news on: Organovo Holdings, Inc., Earnings news and commentary, Stocks on the move, Healthcare stocks news, ,

Actinium Pharmaceuticals (NYSEMKT: ATNM ) initiated with Outperform rating at William Blair. Shares up  9%  premarket. More news on: Actinium Pharmaceuticals, Inc., Omega Healthcare Investors, Inc., Inogen, Inc., Healthcare stocks news, Stocks on the move, , Read more ...

Nano cap Organovo (NASDAQ: ONVO ), once valued at ~$2B during the market's infatuation with regenerative medicine a few years ago, has engaged Roth Capital to advise it on strategic alternatives , adding that it will restructure in order to extend its cash runway. More news on: Organovo H...

SAN DIEGO, Aug. 07, 2019 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ:ONVO) (“Organovo”) today announced that it has engaged Roth Capital Partners (“Roth”) as its financial advisor to assist in the exploration of strategic alternatives. This decision was r...

SAN DIEGO, July 18, 2019 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ:ONVO) (“Organovo”) will host a conference call on Thursday, August 8, 2019 at 5:00 p.m. Eastern Time (ET) to discuss the Company's fiscal first-quarter 2020 operating and financial highlights.  I...